TREADWAY COMPANIES, INC., ET AL.
v.
BRUNSWICK CORP.

U.S. | 1977-02-22
No. 75-770
429 U.S. 1090 Supreme Court of the United States (1977) Negative Treatment
Cited by 28 cases

Opinion

Full opinion text not available for this case.


Cases With Similar Vibessemantic neighbors from the corpus


Citator

Cited By (28 total)

  • …ause of our concern that they had seriously misread or misapplied this statutory and decisional law cautioning reviewing courts against engrafting their own notions of proper procedures upon agencies entrusted with substantive functions by Congress. 429 U. S. 1090 (1977). We conclude that the Court of Appeals has done just that in these cases, and we therefore remand them to it for further proceedings. We also find it necessary to examine the Court of Appeals’ decision with respect to agency action taken aft…
  • Regents of the Univ. of Cal. v. Bakke, 438 U.S. 265 (U.S. 1978)
    …t enter judgment ordering Bakke’s admission to the Medical School. 18 Cal. 3d, at 64, 553 P. 2d, at 1172. That order was stayed pending review in this Court. 429 U. S. 953 (1976). We granted certiorari to consider the important constitutional issue. 429 U. S. 1090 (1977). II In this Court the parties neither briefed nor argued the applicability of Title VI of the Civil Rights Act of 1964. Rather, as had the California court, they focused exclusively upon the validity of the special admissions program under…
  • Memphis Light v. Craft, 436 U.S. 1 (U.S. 1978)
    …es a customer of “property” within the meaning of the Due Process Clause; and (iii) assuming “state action” and a “property” interest, whether MLG&W’s procedures afforded due process of law in this case.6 On February 22, 1977, we granted certiorari, 429 U. S. 1090. We now affirm. II There is, at the outset, a question of mootness. Although the parties have not addressed this question in their briefs, “they may not by stipulation invoke the judicial power of the United States in litigation which does not pre…

Previewing 3 of 28 citing cases — full citator treatment, depth of discussion, and citing context are member features.

Join FLexlaw to unlock all legal intelligence

Full citator, related cases, and AI research tools

Open in FLexlaw